Ampicaps, 250 mg, Hard Capsule

Land: Storbritannien

Språk: engelska

Källa: VMD (Veterinary Medicines Directorate)

Aktiva substanser:

Ampicillin

Tillgänglig från:

Cross Vetpharm Group Ltd

ATC-kod:

amended)

INN (International namn):

Ampicillin

Bemyndigande status:

Expired

Produktens egenskaper

Revised: April 2010
(ATCVet code amended)
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Ampicaps, 250mg, hard capsule
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Active Ingredient
mg per capsule
Ampicillin
250
(as ampicillin trihydrate)
Capsule Body
Erythrosine (E127)
0.952
Quinoline Yellow (E104)
0.004
Patent Blue V (E131)
0.002
Titanium Dioxide (E171)
0.368
Capsule cap
Ferric Oxide black (E172)
0.146
Titanium Dioxide (E171)
0.488
Ink:
Black Iron Oxide (E172)
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Capsule, hard. Red and grey coloured hard gelatine capsule with the
logo,
AMP 250, in black ink.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Dogs.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Indicated in the treatment and control of diseases caused by or
associated
with bacterial pathogens sensitive to ampicillin. These include the
following
groups of pathogens:
_Streptococcus_ spp., _Pasturella haemolitica, P. multocida,
Staphylococcus _
_aureus _and other pathogenic staphylococci.
Page 1 of 5
Revised: April 2010
(ATCVet code amended)
When susceptible organisms are present treatment may be effective in
the
following indications:
alimentary tract infections
respiratory infections
urinary tract infections
4.3
CONTRAINDICATIONS
Not to be administered to animals known to be sensitive to penicillin.
Not to be administered to small herbivores.
Do not treat dogs of less than 10 kg bodyweight.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
As with all penicillins, the product may cause hypersensitivity
(allergy)
following ingestion. It should not be used when the dog is known to be
allergic
to penicillins.
As with all other penicillins, bacterial resistance to ampicillin may
occur. Thus
antibiotic sensitivity testing should be considered if a clinical
condition fails to
respond to treatment within 3 to 5 days.
4.5
SPECIAL PRECAUTIONS FOR USE
i.
Special precautions for use in animals
For oral administration only.
ii.
Special precautions to be taken by the